CI

At a glance

ClinicalIndex Comparison Record
Phase 2Active· 48 enrolled
Drug / intervention
Acupuncture +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04007770
NCT04007770Phase 2Active

Cancer-related Cognitive Function Acupuncture Pilot Study (CLARITY

Memorial Sloan Kettering Cancer Center·interventional·Posted Jul 5, 2019·Updated May 22, 2026

In Brief

A Phase 2 clinical trial evaluating Acupuncture, Sham Acupuncture, and 1 other intervention for Stage I Breast Cancer and 12 related conditions. Active but no longer recruiting, targeting 48 participants across 6 sites.

Detailed Summary

This study is being done to explore whether acupuncture can improve cognitive difficulties in patients diagnosed with cancer.

Study Details

Timeline

Phase 2ActiveOverdue
2020202120222023202420252026
First PostedJul 5, 2019
Enrollment StartJul 1, 2019
Primary CompletionJul 1, 2026
TodayJul 1, 2026
Enrollment to primary: 7 yearsPosted 7.0 years ago

Interventions

Acupunctureother

10 treatments of acupuncture over the course of 10 weeks with a +/- 7 day window

Sham Acupunctureother

10 treatments of sham acupuncture over the course of 10 weeks with a +/- 7 day window. After the 16-week study concludes patients in this group will have the option of receiving up to 10 sessions of real acupuncture; however, these sessions must be completed within 6 months of study conclusion.

16 week waiting period + optional Acupunctureother

Optional real acupuncture after 16 weeks waiting period. This arm is Closed to accrual.